Ron Protein, Active

• Description:

  Ron Protein, Active_x000D_ Catalog number: B2019375_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5  µg_x000D_ Molecular Weight or Concentration: 74.2 kDa_x000D_ Supplied as: Resin_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: −70°C_x000D_ Keywords: Ron Protein, Active_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Hunt BG, Fox LH, Davis JC, Jones A, Lu Z, Waltz SE. An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling Genes (Basel). 2023 Feb 17;14(2):517._x000D_ 2: Wang MH, Zhou YQ, Chen YQ. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities Scand J Immunol. 2002 Dec;56(6):545-53._x000D_ 3: Danilkovitch A, Leonard EJ. Kinases involved in MSP/RON signaling J Leukoc Biol. 1999 Mar;65(3):345-8._x000D_ 4: Wang MH, Wang D, Chen YQ. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase Carcinogenesis. 2003 Aug;24(8):1291-300._x000D_ 5: Faham N, Welm AL. RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers Cold Spring Harb Symp Quant Biol. 2016;81:177-188._x000D_ 6: Huang L, Fang X, Shi D, Yao S, Wu W, Fang Q, Yao H. MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity Front Immunol. 2020 Oct 7;11:569082._x000D_ 7: Kretschmann KL, Eyob H, Buys SS, Welm AL. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression Curr Drug Targets. 2010 Sep;11(9):1157-68._x000D_ 8: Chakedis J, French R, Babicky M, Jaquish D, Mose E, Cheng P, Holman P, Howard H, Miyamoto J, Porras P, Walterscheid Z, Schultz-Fademrecht C, Esdar C, Schadt O, Eickhoff J, Lowy AM. Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics Oncotarget. 2016 Jul 19;7(29):45959-45975._x000D_ 9: Franco Nitta C, Green EW, Jhamba ED, Keth JM, Ortiz-Caraveo I, Grattan RM, Schodt DJ, Gibson AC, Rajput A, Lidke KA, Wilson BS, Steinkamp MP, Lidke DS. EGFR transactivates RON to drive oncogenic crosstalk Elife. 2021 Nov 25;10:e63678._x000D_ 10: Benight NM, Waltz SE. Ron receptor tyrosine kinase signaling as a therapeutic target Expert Opin Ther Targets. 2012 Sep;16(9):921-31. _x000D_ _x000D_ Products Related to Ron Protein, Active can be found at Proteins

• Short Description:

  Catalog Number: B2019375 (5  µg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5